Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
← catalyst calendarSponsored by Vanda Pharmaceuticals (industry) · VNDA — their whole pipeline →.
Phase
Phase 3
Status
Recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
100estimated
Sites
3
Countries
Belgium, Germany
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-01-09 | actual | When the study began enrolling |
| Primary completion | Dec 2025 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2025 | estimated | The whole study's end, after follow-up |
| First posted | 2025-02-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-02-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Idiopathic Gastroparesis
- Diabetic Gastroparesis
- Gastroparesis
Intervention
- Drug: Tradipitant
Primary outcomes
what the primary-completion date above is the date OFNumber of participants with adverse events (AEs), including suicidal ideation or behavior as measured by the C-SSRS
measured 12 weeks
Number of participants with changes in vital signs identified as Clinically Notable Abnormal values
measured 12 weeks
Number of participants with abnormal and potentially Clinically Notable Abnormal Electrocardiogram Intervals and Heart Rate
measured 12 weeks
Number of participants with Clinically Notable Abnormal laboratory values
measured 12 weeks
Permalink · VNDA's whole pipeline · Catalyst calendar · Every registered study · What changed